Precision Biosciences Inc
DTIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357874
In the last 90 days, Precision Biosciences Inc insiders filed 3 open-market purchases and 0 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $138.9M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Precision Biosciences Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 131 | 2 | 132 | +3 |
| Shares | 28.7M | 148.6K | 29.2M | +584.4K (+2.0%) |
| Value | $357.6M | $1.86M | $336.5M | −$19.2M (−5.4%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Precision Biosciences Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 325,000 | $3.75M | 0.01% |
| Marshall Wace, LLP | 180,129 | $2.08M | 0.01% |
| Opaleye Management Inc. | 163,900 | $1.89M | 0.35% |
| Healthcare of Ontario Pension Plan Trust Fund | 150,100 | $1.73M | 0.00% |
| Cinctive Capital Management LP | 75,000 | $866.0K | 0.05% |
| Gsa Capital Partners LLP | 55,431 | $640.0K | 0.07% |
| HighTower Advisors, LLC | 41,239 | $476.0K | 0.00% |
| Prudential Financial Inc | 23,250 | $268.0K | 0.00% |
| SG Americas Securities, LLC | 22,221 | $256.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 11,482 | $133.0K | 0.00% |
| Squarepoint Ops LLC | 10,500 | $121.0K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 7,021 | $81.0K | 0.00% |
| Close Asset Management Ltd | 5,000 | $58.0K | 0.00% |
| Macquarie Group Ltd | 4,780 | $55.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,909 | $22.0K | 0.00% |
| Koshinski Asset Management, Inc. | 300 | $3.46K | 0.00% |
| TSFG, LLC | 100 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Precision Biosciences Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Price T Rowe Associates Inc | 596,992 | $7.47M |
| Voloridge Investment Management, LLC | 165,598 | $2.07M |
| Point72 Asset Management, L.P. | 115,400 | $1.45M |
| Renaissance Technologies LLC | 101,125 | $1.27M |
| Jump Financial, LLC | 79,400 | $994.0K |
| Schonfeld Strategic Advisors LLC | 35,488 | $444.0K |
| TD Asset Management Inc | 34,689 | $342.0K |
| Trexquant Investment LP | 24,455 | $306.0K |
| Vident Investment Advisory, LLC | 19,735 | $247.0K |
| Blueshift Asset Management, LLC | 18,003 | $225.0K |
| Dynamic Technology Lab Private Ltd | 13,681 | $171.0K |
| Change Path, LLC | 11,475 | $144.0K |
| Hancock Whitney Corp | 10,719 | $134.0K |
| Ironsides Asset Advisors, LLC | 10,503 | $131.0K |
Not filed for Q3 2021 yet (2)
Institutions that held Precision Biosciences Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Nachman Norwood & Parrott, Inc | 148,456 | $1.86M |
| CWM, LLC | 114 | $1.00K |